FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide) July 28, 2021 Auto Bot News 0 FDA alerts patients and health care professionals that a clinical trial evaluating Pepaxto (melphalan flufenamide) showed an increased risk of death.
